our approach

We bridge the gap

Over the last decade, venture capital funding shifted away from early-stage companies in favour of later-stage opportunities in an effort to minimize risk, creating a financing gap in the commercialization pathway.

Accel-Rx was created to bridge that gap and is the only organization with a national perspective addressing these specific growth challenges.

Stage of development and funding source
Accel-rx stages of funding graph Accel-rx stages of funding graph Accel-rx stages of funding graph

Accel-Rx, and founding partner, BDC Capital, provide up to $1M in funding which is further matched by third-party investors. Supporting capital financing needs is just one part of the solution – Accel-Rx also offers a full range of programs to address early-stage operating needs including mentorship, business services, training, and networking.

investment philosophy


Accel-Rx invests in promising start-ups by providing an infusion of capital and talent in order to support the growth into venture-ready companies (able to raise a series A or similar financing) within 18 to 24 months. Investment decisions are made based on internal and external diligence as well as a recommendation by the Accel-Rx Investment Committee, which is comprised of industry experts from a range of therapeutic and specialty areas.

 

Investment by Accel-Rx is a competitive process and therefore funding decisions rely heavily on our comprehensive screening process.

 

Providing they meet eligibility requirements, opportunities are evaluated based on the following investment criteria:

 

  • Pharmaceutical, medical device or diagnostic product
  • Quality and competitive advantage of technology
  • High growth and unmet market opportunity
  • Quality of the management
  • Validated development plan
  • Impact of seed money: getting to a value inflection point
  • Type of co-investors (required third-party match)
  • Scope and strength of IP protection
  • Participation in Accel-Rx programs
  • Return on investment for Accel-Rx and its stakeholders
investment philosophy

Impact

10

Portfolio
companies

Number of companies Accel-Rx has invested in

$5.0M

Investment

Amount of seed capital invested by Accel-Rx

100+

Partners

Partnerships that contribute to Accel-Rx mandate

220

Community
Service
Hours

Number of hours Accel-Rx contributed to ecosystem and external initiatives

26

mentor
relationships

Number of CEOs and company relationships in Accel-Rx Mentor Program

$39.7M

Follow-on
Financing

Total amount of follow-on

200

Companies
Screened

Number of companies Accel-Rx has filtered and reviewed for investment purposes

8.9

Our
Leverage
Ratio

Ratio of external funding to Accel-Rx investment

$44.6M

Co-investment

Amount of money co-invested by external investors

16

Investors
engaged

Number of co-investors in Accel-Rx investments excluding Angels

$4.96M

Average
deal
size

Average dollar amount per deal

meet our leadership team

who we are